Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 5, 2014, Pages 1065-1072

  Yu, Xueping ^a   Guo, Ruyi ^a   Ming, Desong ^a   Su, Milong ^a   Lin, Chengzu ^a   Deng, Yong ^a   Lin, Zhenzhong ^a   Su, Zhijun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Interleukin 17; Liver cirrhosis; TGF 1; Th17 cells; Treg cells

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHILD PUGH SCORE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE COURSE; END STAGE LIVER DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY; SURVIVAL; TH17 CELL; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADULT; DISEASE PROGRESSION; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-17; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84898898987     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12459     Document Type: Article

References (29)

1. Wong GL, Wong VW, Choi PC etal. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-117.
2. Lim YS, Kim W. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 2008; 12: 733-746.
3. Stoop JN, van der Molen RG, Baan CC etal. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-778.
4. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123: 57-65.
5. Lina C, Conghua W, Nan L, Ping Z. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J. Clin. Immunol. 2011; 31: 596-605.
6. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 2002; 7: d793-807.
7. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res. 2010; 20: 4-12.
8. Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J. Viral Hepat. 2012; 19: 396-403.
9. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009; 27: 485-517.
10. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 2010; 10: 159-169.
11. Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010; 5: e13869.
12. Niu Y, Liu H, Yin D etal. The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol. 2011; 12: 47.
13. Wang Q, Zheng Y, Huang Z etal. Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol. 2011; 12: 25.
14. Tritto G, Bechlis Z, Stadlbauer V etal. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J. Hepatol. 2011; 55: 574-581.
15. Papatheodoridis GV, Manolakopoulos S. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. J. Hepatol. 2009; 51: 226-227.
16. Zhai S, Zhang L, Dang S etal. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol. 2011; 24: 303-310.
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-649.
18. Kamath PS, Wiesner RH, Malinchoc M etal. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
19. Karino Y, Toyota J, Kumada H etal. Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B. Hepatol. Int. 2010; 4: 414-422.
20. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011; 6: 425-456.
21. Friedman SL. Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol. 2010; 7: 425-436.
22. Li J, Qiu SJ, She WM etal. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One 2012; 7: e39307.
23. Zhang JP, Yan J, Xu J etal. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 2009; 50: 980-989.
24. Fu J, Xu D, Liu Z etal. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007; 132: 2328-2339.
25. Wahl S, McCartney-Francis N, Allen J, Dougherty E, Dougherty S. Macrophage production of TGF-β and regulation by TGF-β. Ann. N. Y. Acad. Sci. 1990; 593: 188-196.
26. Oukka M. Interplay between pathogenic Th17 and regulatory T cells. Ann. Rheum. Dis. 2007; 66: iii87-iii90.
27. Su ZJ, Yu XP, Guo RY etal. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B. Diagn. Microbiol. Infect. Dis. 2013; 76: 437-444.
28. Zhang JY, Zhang Z, Lin F etal. Interleukin-17-producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91.
29. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin. Liver Dis. 2007; 27: 339-350.